RNA processing Knowledge-Based Study

Study notes

1. Overview of Eukaryotic Transcript Modification

   In eukaryotic cells, transcription of a protein-coding gene by RNA polymerase II yields a primary transcript known as pre-mRNA (precursor messenger RNA). Unlike prokaryotes, where translation can occur concurrently with transcription, eukaryotic pre-mRNA must undergo extensive nuclear modifications before being exported to the cytoplasm as functional mature mRNA.

   These coordinated post-transcriptional modifications include:

   • Addition of a 5' cap
   • Addition of a 3' poly-A tail
   • RNA splicing (removal of introns and ligation of exons)

   Collectively, these processes protect the transcript from degradation, facilitate nuclear export, assist in ribosome binding, and generate proteomic diversity.

   End Modifications of Pre-mRNA

   Both termini of the primary transcript are modified during or immediately after synthesis to ensure stability and proper recognition by translational machinery.

   5' 7-Methylguanosine Cap

   Early during transcription elongation, a modified guanine nucleotide is attached to the 5' end through an unusual 5'-to-5' triphosphate linkage. This structure is subsequently methylated to form the 7-methylguanosine (m7G) cap. The 5' cap serves critical functions:

   • Protects the nascent mRNA from degradation by 5' exonucleases.
   • Serves as a binding site for the cap-binding complex (CBC) to facilitate nuclear export.
   • Provides a direct recognition signal for the eukaryotic translation initiation factor complex in the cytoplasm.

   3' Cleavage and Polyadenylation

   At the opposite terminus, transcription proceeds past a conserved polyadenylation signal sequence (typically AAUAAA). Specific endonucleases cleave the transcript downstream of this signal. The enzyme poly-A polymerase (PAP) then adds a non-templated sequence of approximately 100 to 250 adenine residues, creating the poly-A tail.

   The poly-A tail protects the 3' terminus from enzymatic digestion by 3' exonucleases and works cooperatively with the 5' cap to enhance translation efficiency.

   Intron Removal and Exon Ligation

   Eukaryotic pre-mRNAs are mosaic molecules composed of coding sequences called exons interspersed with non-coding intervening sequences known as introns. For mature mRNA to code for a continuous functional polypeptide, introns must be excised precisely.

   The Spliceosome Mechanism

   RNA splicing is catalyzed by a macromolecular ribonucleoprotein machine called the spliceosome. The spliceosome is assembled from five small nuclear ribonucleoproteins (snRNPs, designated U1, U2, U4, U5, and U6) along with numerous accessory proteins.

   Splicing proceeds through key conserved sequence landmarks within each intron:

   • 5' Splice Site: A conserved boundary marked by a GU dinucleotide.
   • Branch Point: An internal adenine nucleotide located upstream of the 3' end of the intron.
   • 3' Splice Site: A conserved boundary terminating with an AG dinucleotide.

   The splicing reaction occurs via two successive transesterification steps. First, the 2'-OH group of the branch point adenine attacks the phosphodiester bond at the 5' splice site, forming a branched lariat structure. Second, the liberated 3'-OH of the 5' exon attacks the 3' splice site, ligating the two exons together and releasing the intron lariat for degradation.

   Generating Functional Diversity from a Single Gene

   Splicing is not always constitutive. Through alternative splicing, different combinations of exons from the same pre-mRNA molecule can be selectively included or excluded in the mature mRNA transcript.

   Mechanisms of alternative splicing include:

   • Exon Skipping: A specific cassette exon is either included or skipped.
   • Alternative 5' or 3' Splice Sites: Subtle shifts in splice site choice alter the length of an exon.
   • Intron Retention: An intron is retained in the mature transcript rather than excised.
   • Mutually Exclusive Exons: Only one of two adjacent exons is retained in a given isoform.

   Alternative splicing explains how the human genome, containing roughly 20,000 protein-coding genes, can produce over 100,000 distinct functional protein isoforms. This mechanism provides essential tissue-specific regulation and developmental flexibility across eukaryotic organisms.